NCT00410735

Study of ONO-1078 in Patients With Chronic Sinusitis

Study of ONO-1078 in Patients With Chronic Sinusitis, a Double-blind, Randomized, Placebo-controlled, Parallel Group, Multi-center Study

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 495 (actual)
• Sponsor: Ono Pharmaceutical Co., Ltd. · Industry
• Sex: All
• Age: 15 Years – 74 Years
• Healthy volunteers: Not accepted

Summary

To determine the efficacy and safety of ONO-1078 in patients with chronic sinusitis in a double-blind, randomized, placebo-controlled, parallel group, multi-center study

Conditions

• Chronic Sinusitis

Interventions

Type	Name	Description
DRUG	Placebo	0 mg BID for 12 weeks
DRUG	Pranlukast hydrate	225 mg BID for 12 weeks

Timeline

• Start date: 2006-12-01
• Primary completion: 2008-06-01
• First posted: 2006-12-13
• Last updated: 2012-06-13

Locations

6 sites across 1 country: Japan